Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.
Ashray RajagopalanSomaiah ArooriThomas B RussellPeter L LabibFabio AusaniaElizabeth PandoKeith J RobertsAmbareen KausarVasileios K MavroeidisGabriele MarangoniSarah C ThomassetAdam E FramptonPavlos LykoudisManuel MaglioneNassir AlhaboobHassaan BariAndrew M SmithDuncan SpaldingParthi SrinivasanBrian R DavidsonRicky H BhogalIsmael DominguezRohan ThakkarDhanny GomezMichael A SilvaPierfrancesco LapollaAndrea MingoliAlberto PorcuNehal S ShahZaed Z R HamadyBilal Al-SarriehAlejandro SerrabloDaniel Croaghnull nullPublished in: HPB : the official journal of the International Hepato Pancreato Biliary Association (2024)
We found no difference in five-year recurrence and survival between diabetic patients and those without diabetes. Patients with pre-existing DM should be evaluated for PD on a comparable basis to non-diabetic patients.